Copyright
©The Author(s) 2022.
World J Clin Pediatr. May 9, 2022; 11(3): 239-252
Published online May 9, 2022. doi: 10.5409/wjcp.v11.i3.239
Published online May 9, 2022. doi: 10.5409/wjcp.v11.i3.239
Table 1 Showing majority of sleep disorders can be grouped into 6 main categories
Category | Description | Conditions and causes, some examples | |
Insomnias | Inability to fall asleep or stay asleep | Environmental: Poor sleep hygiene, bedroom noise, bright light. Behavioural insomnia of childhood (sleep onset/limit setting/combined). Psychiatric, trauma and substance misuse: Anxiety, depression, OCD, PTSD, abuse or neglect, bullying, drug and substance misuse. Medical: Pain (headaches, joint pains), lung problems (asthma, cystic fibrosis), skin (eczema, allergies), neuromuscular, obesity, medication side effects | |
Sleep related breathing disorders | Breathing difficulties during sleep | Obstructive sleep apnoea. Central sleep apnoea | |
Central disorders of hypersomnolence | Excessively sleepy | Narcolepsy | |
Circadian rhythm sleep-wake disorders | Sleep times are out of alignment | Delayed sleep phase syndrome. Jet lag | |
Parasomnias | Unwanted events or experiences that occur at the time of falling asleep, sleeping or waking up | During NREM sleep | Confusional arousals. Sleep terrors. Sleep-walking |
During REM sleep | Nightmares | ||
Others | Enuresis | ||
Sleep related movement disorders | Unusual body movements during sleep | Bruxism. Restless legs syndrome. Periodic limb movement disorder. Rhythmic movement disorder (head banging, body rocking) |
Table 2 Showing positive effects and negative consequences
Positive effects of adequate and good quality sleep | Negative consequences of lack of adequate and good quality sleep |
Promotes growth. Strengthens immunity. Helps cell growth and body repair. Consolidates memory (https://www.sleepscotland.org/support/gateway-to-good-sleep/why-is-sleep-important/). Promotes learning and cognitive development[69]. Maintains physical health and emotional wellbeing | Increased association with excess weight gain and obesity[69]. Impairs immune function. Affects physical coordination. Affects ability to learn new information and problem solve. Affects mood and emotional regulation and increases risk of mental health problems e.g., mood or anxiety disorder, suicidal ideation |
Table 3 Showing National Sleep Foundation’s sleep duration recommendations (https://www.sleepfoundation.org/press-release/national-sleep-foundation-recommends-new-sleep-times)
Age of the child | Recommended | May be appropriate | Not recommended |
Pre-schoolers (3-5 yr) | 10-13 h | 8-14 h | Less than 8 h or more than 14 h |
School-aged children (6-13 yr) | 9-11 h | 7-12 h | Less than 7 h or more than 12 h |
Teenagers (14-17 yr) | 8-10 h | 7-11 h | Less than 7 h or more than 11 h |
Table 4 Below illustrates some useful resources
Table 5 Showing drugs used to treat insomnia[17]
Pharmaceutical | Class | Mechanism of action | Half life (h) | Site of metabolism | Peak concentration | Interactions | Effect on sleep |
Diphenhydramine | Antihistamine | H1 agonist. Crosses blood-brain barrier | 4-6 | Hepatic | Fast absorption. Fast onset of action. Peak at 2-4 h | CNS depressants | Reduces latency. May decrease quality |
Hydroxyzine | Antihistamine | H1 agonist. Crosses blood-brain barrier | 6-24 | Hepatic | Fast absorption. Fast onset of action. Peak at 2-4 h | CNS depressants | Reduces latency. May decrease quality |
Melatonin | Neuro-hormone | Hypnotic | 90% excreted in 4 | Hepatic | 30-60 min | Unknown | Reduces latency. Maximum circadian effect |
Clonazepam | Benzodiazepine | Central GABA receptors | 30-40 | CYP 450 3A oxidation | 60-240 min | Fluoxetine | Suppresses slow-wave sleep. Reduces arousal |
Flurazepam | Benzodiazepine | Central GABA receptors | 2-100 | CYP 450 3A oxidation | 30 min to 13 h | Fluoxetine | Suppresses slow-wave sleep. Reduces arousal |
Zolpidem | Z-drug | Benzodiazepine-like | 2.5-3 | CYP 450 3A oxidation | 90 min | Reduces latency. Weak effect on sleep architecture | |
Clonidine | Alpha agonist | Inhibits noradrenaline release | 6-24 | 50%-80% in urine | Fast absorption 100% bioavailability. Onset of action: 1 h. Peak effect: 2-4 h | Reduce REM. Reduces slow-wave sleep |
- Citation: Ogundele MO, Yemula C. Management of sleep disorders among children and adolescents with neurodevelopmental disorders: A practical guide for clinicians. World J Clin Pediatr 2022; 11(3): 239-252
- URL: https://www.wjgnet.com/2219-2808/full/v11/i3/239.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v11.i3.239